Equities research analysts predict that II-VI, Inc. (NASDAQ:IIVI) will post $0.65 earnings per share for the current fiscal quarter, Zacks Investment Research reports. Five analysts have provided estimates for II-VI’s earnings, with the lowest EPS estimate coming in at $0.64 and the highest estimate coming in at $0.67. II-VI reported earnings of $0.36 per share in the same quarter last year, which would suggest a positive year-over-year growth rate of 80.6%. The business is scheduled to announce its next quarterly earnings report on Tuesday, May 7th.

According to Zacks, analysts expect that II-VI will report full-year earnings of $2.61 per share for the current fiscal year, with EPS estimates ranging from $2.54 to $2.68. For the next financial year, analysts anticipate that the business will post earnings of $3.07 per share, with EPS estimates ranging from $2.83 to $3.33. Zacks Investment Research’s earnings per share calculations are an average based on a survey of sell-side research analysts that follow II-VI.

II-VI (NASDAQ:IIVI) last announced its quarterly earnings data on Thursday, January 3rd. The scientific and technical instruments company reported $0.44 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.46 by ($0.02). II-VI had a return on equity of 10.93% and a net margin of 8.81%. The business had revenue of $342.84 million during the quarter, compared to the consensus estimate of $339.22 million.

Several research firms have issued reports on IIVI. Zacks Investment Research cut shares of II-VI from a “buy” rating to a “hold” rating in a research note on Friday, January 18th. BidaskClub cut shares of II-VI from a “hold” rating to a “sell” rating in a research note on Saturday, March 9th. ValuEngine lowered shares of II-VI from a “buy” rating to a “hold” rating in a report on Sunday, March 3rd. Finally, Benchmark reissued a “buy” rating and issued a $55.00 target price on shares of II-VI in a report on Friday, February 1st. Two analysts have rated the stock with a sell rating, four have issued a hold rating and eight have issued a buy rating to the company’s stock. II-VI presently has a consensus rating of “Hold” and a consensus target price of $49.09.

II-VI stock traded up $0.09 during mid-day trading on Friday, reaching $37.04. 6,716 shares of the company traded hands, compared to its average volume of 596,298. The company has a current ratio of 3.17, a quick ratio of 2.00 and a debt-to-equity ratio of 0.43. The company has a market cap of $2.36 billion, a P/E ratio of 21.78, a PEG ratio of 1.27 and a beta of 0.85. II-VI has a 52-week low of $29.31 and a 52-week high of $50.75.

In other II-VI news, CFO Mary Jane Raymond sold 2,000 shares of the stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $39.00, for a total transaction of $78,000.00. Following the completion of the sale, the chief financial officer now directly owns 49,464 shares of the company’s stock, valued at approximately $1,929,096. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Francis J. Kramer sold 10,000 shares of the stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $40.02, for a total transaction of $400,200.00. Following the sale, the director now directly owns 172,647 shares of the company’s stock, valued at $6,909,332.94. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 57,517 shares of company stock valued at $2,300,042. Insiders own 4.00% of the company’s stock.

Institutional investors and hedge funds have recently made changes to their positions in the business. First Trust Advisors LP boosted its position in shares of II-VI by 66.7% during the 3rd quarter. First Trust Advisors LP now owns 64,870 shares of the scientific and technical instruments company’s stock valued at $3,068,000 after acquiring an additional 25,949 shares during the last quarter. Janney Montgomery Scott LLC bought a new position in shares of II-VI during the 3rd quarter valued at approximately $258,000. Stone Ridge Asset Management LLC bought a new position in shares of II-VI during the 3rd quarter valued at approximately $212,000. Prudential Financial Inc. boosted its position in shares of II-VI by 4.9% during the 3rd quarter. Prudential Financial Inc. now owns 98,398 shares of the scientific and technical instruments company’s stock valued at $4,654,000 after acquiring an additional 4,623 shares during the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in shares of II-VI by 20.5% during the 3rd quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 14,035 shares of the scientific and technical instruments company’s stock valued at $664,000 after acquiring an additional 2,392 shares during the last quarter. 91.85% of the stock is owned by institutional investors and hedge funds.

II-VI Company Profile

II-VI Incorporated develops, manufactures, and markets engineered materials, and optoelectronic components and devices worldwide. The company operates in three segments: II-VI Laser Solutions, II-VI Photonics, and II-VI Performance Products. The II-VI Laser Solutions segment offers optical and electro-optical components and materials primarily used in high-power CO2 lasers; fiber-delivered beam delivery systems, and processing tools and direct diode lasers for industrial lasers; direct diode laser modules, sub-systems, and systems; super-hard materials processing laser systems; and compound semiconductor epitaxial and gallium arsenide wafers.

Featured Article: Yield Curve

Get a free copy of the Zacks research report on II-VI (IIVI)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for II-VI (NASDAQ:IIVI)

Receive News & Ratings for II-VI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for II-VI and related companies with MarketBeat.com's FREE daily email newsletter.